In this webinar, you'll explore the impact of RSV on U.S. infants, examine key clinical studies on nirsevimab, and review global real-world data on its effectiveness. You'll also learn how to implement immunization strategies to reduce RSV lower respiratory tract infections (LRTI), with practical takeaways for improving coverage and reimbursement decisions.
